ERBB2 and metastatic neoplasm: Focusing on HER2 status, HER2 discordance has so far been investigated by dichotomizing cases between HER2-positive vs HER2-negative or, as recently reported, by considering the evolution from primary to metastatic disease of IHC-based scores in HER2-low primary breast cancer20.